The forecast for influenza mortality in Brazil among females remains constant at a standardized rate of 600 deaths per hundred women from 2024 to 2028. This consistent figure indicates no year-on-year change from previous forecasts, suggesting stability in mortality projections. In 2023, the standardized rate aligned with these forecasts, making the five-year compound annual growth rate (CAGR) effectively zero, as there is no fluctuation expected.

Future trends to watch include:

Potential impacts of new antiviral treatments or vaccine updates on mortality rates.
Effects of evolving influenza virus strains and their distribution.
Increased healthcare access or public health campaigns that could alter these projections.